Rock Springs Capital Management LP Q3 2024 Filing
Filed November 14, 2024
Portfolio Value
$3.1B
Holdings
109
Report Date
Q3 2024
Filing Type
13F-HR
All Holdings (109 positions)
| Stock | Value |
|---|---|
SPRBSPRUCE BIOSCIENCES INC | $1.0B |
ISRGINTUITIVE SURGICAL INC | $132.0M |
RAREULTRAGENYX PHARMACEUTICAL IN | $109.0M |
NBIXNEUROCRINE BIOSCIENCES INC | $108.0M |
EXASEXACT SCIENCES CORP | $78.0M |
2L9BLUEPRINT MEDICINES CORP | $71.0M |
ALNYALNYLAM PHARMACEUTICALS INC | $68.0M |
TVTXTRAVERE THERAPEUTICS INC | $65.0M |
RYTMRHYTHM PHARMACEUTICALS INC | $64.0M |
FRPTFRESHPET INC | $61.0M |
MIRMMIRUM PHARMACEUTICALS INC | $61.0M |
EVHEVOLENT HEALTH INC | $58.0M |
MDGLMADRIGAL PHARMACEUTICALS INC | $55.0M |
PHRPHREESIA INC | $52.0M |
PENPENUMBRA INC | $51.0M |
ACHCACADIA HEALTHCARE COMPANY IN | $51.0M |
XENEXENON PHARMACEUTICALS INC | $51.0M |
WSTWEST PHARMACEUTICAL SVSC INC | $50.0M |
IM8NINSMED INC | $49.0M |
KYMRKYMERA THERAPEUTICS INC | $49.0M |
ASNDASCENDIS PHARMA A/S | $48.0M |
HUMHUMANA INC | $46.0M |
GPCRSTRUCTURE THERAPEUTICS INC | $46.0M |
RVMDREVOLUTION MEDICINES INC | $45.0M |
MRUSMERUS N V | $44.0M |
NUVLNUVALENT INC | $43.0M |
MREOMEREO BIOPHARMA GROUP PLC | $39.0M |
SRPTSAREPTA THERAPEUTICS INC | $38.0M |
BSXBOSTON SCIENTIFIC CORP | $38.0M |
EWEDWARDS LIFESCIENCES CORP | $38.0M |
TCE2CELLDEX THERAPEUTICS INC NEW | $37.0M |
DC4DEXCOM INC | $35.0M |
AGLAGILON HEALTH INC | $35.0M |
IMVTIMMUNOVANT INC | $34.0M |
AGIOAGIOS PHARMACEUTICALS INC | $31.0M |
PODDINSULET CORP | $31.0M |
ZLABZAI LAB LTD | $31.0M |
AFWALIGN TECHNOLOGY INC | $29.0M |
IRTCIRHYTHM TECHNOLOGIES INC | $29.0M |
BCRXBIOCRYST PHARMACEUTICALS INC | $27.0M |
INSPINSPIRE MED SYS INC | $27.0M |
AKROAKERO THERAPEUTICS INC | $26.0M |
AZTAAZENTA INC | $25.0M |
LEGNLEGEND BIOTECH CORP | $24.0M |
WRBYWARBY PARKER INC | $23.0M |
SMMTSUMMIT THERAPEUTICS INC | $22.0M |
LFSTLIFESTANCE HEALTH GROUP INC | $21.0M |
OSCROSCAR HEALTH INC | $21.0M |
INZYINOZYME PHARMA INC | $19.0M |
DYNDYNE THERAPEUTICS INC | $16.0M |
VERAVERA THERAPEUTICS INC | $16.0M |
NVONOVO-NORDISK A S | $15.0M |
PHVSPHARVARIS N V | $14.0M |
APLTAPPLIED THERAPEUTICS INC | $14.0M |
CRNXCRINETICS PHARMACEUTICALS IN | $14.0M |
ZBIOZENAS BIOPHARMA INC | $14.0M |
NUVB/WSNUVATION BIO INC | $13.1M |
AM6AMICUS THERAPEUTICS INC | $13.0M |
JNJJOHNSON & JOHNSON | $12.0M |
CGEMCULLINAN THERAPEUTICS INC | $12.0M |
BCAXBICARA THERAPEUTICS INC | $11.0M |
PRTAPROTHENA CORP PLC | $10.0M |
NMRANEUMORA THERAPEUTICS INC. | $10.0M |
KRYSKRYSTAL BIOTECH INC | $10.0M |
CYTKCYTOKINETICS INC | $10.0M |
BMRNBIOMARIN PHARMACEUTICAL INC | $10.0M |
CMPXCOMPASS THERAPEUTICS INC | $10.0M |
ELVNENLIVEN THERAPEUTICS INC | $10.0M |
JSPRJASPER THERAPEUTICS INC | $8.0M |
XNCRXENCOR INC | $8.0M |
AUPHAURINIA PHARMACEUTICALS INC | $8.0M |
NVV1NOVAVAX INC | $8.0M |
NVROEURNEVRO CORP | $7.0M |
DVAXDYNAVAX TECHNOLOGIES CORP | $6.0M |
SWTXSPRINGWORKS THERAPEUTICS INC | $6.0M |
PCRXPACIRA BIOSCIENCES INC | $6.0M |
BHVNBIOHAVEN LTD | $6.0M |
BEAMBEAM THERAPEUTICS INC | $6.0M |
LUNGPULMONX CORP | $5.0M |
NAMSNEWAMSTERDAM PHARMA COMPANY | $5.0M |
CATXPERSPECTIVE THERAPEUTICS INC | $5.0M |
GOSS 5 06/01/27GOSSAMER BIO INC | $5.0M |
ABOSACUMEN PHARMACEUTICALS INC | $5.0M |
—MERSANA THERAPEUTICS INC | $5.0M |
EPIEURESSA PHARMA INC | $4.0M |
PLRXPLIANT THERAPEUTICS INC | $4.0M |
CYPHLEAP THERAPEUTICS INC | $3.0M |
ACRSACLARIS THERAPEUTICS INC | $3.0M |
MGNXMACROGENICS INC | $3.0M |
EDAEDAP TMS S A | $3.0M |
AUTLAUTOLUS THERAPEUTICS PLC | $3.0M |
GOSSGOSSAMER BIO INC | $3.0M |
SGMTSAGIMET BIOSCIENCES INC | $2.0M |
ADAPYADAPTIMMUNE THERAPEUTICS PLC | $2.0M |
XLOXILIO THERAPEUTICS INC | $2.0M |
APLSAPELLIS PHARMACEUTICALS INC | $2.0M |
VIGLVIGIL NEUROSCIENCE INC | $1.0M |
BMEABIOMEA FUSION INC | $1.0M |
KRROKORRO BIO INC | $1.0M |
CGENCOMPUGEN LTD | $1.0M |
Page 1 of 2Next